Humanity Georgia company has entered the Georgian pharmaceutical market. According to the business registry, the company was registered in May 2015. Humanity Georgia will introduce a wide option of medications to the pharmaceutical market in the near future.
Quality of the company-manufactured medications is approved by the manufacturer’s EU GMP Certificate.
The first set of drugs will be represented by frequently-used drugs at the end of December 2015.
Andrey Kuzma Director of a company notes that, the quality of their drugs is approved by producer’s EU GMP certificate and also by the WHO laboratory which has carried out series of control.
Our company is a young, but we have advantage of having world’s best experts in our management, who have very good experience. The most of our employees have worked for such brands as SANOFI, PFIZER and etc. Humanity Georgia is dynamically developed company, with ambitious plans. We aim to establish our name as the affordable, safe and high quality supplier company of drugs.
Specialists, doctors and even politicians positively appraise that a new company will operate on the Georgian pharmaceutical market. The fact will boost competition on the domestic market and medications will become more affordable, the noted.
Medical adviser Tina Turdziladze overviews the importance and performance of the new pharmaceutical company:
“Humanity Georgia was registered as a joint stock company in Georgia in April 2015. The company is owned by a sole stakeholder. The company’s commodity portfolio consists of generic copies of Indian and Chinese origins, including peculiar (against chronic diseases) and widely-applied drugs. It is necessary that a pharmaceutical company possess the manufacturer’s EU GMP certificate and a world health organization (WHO) certificate as a proof of medications quality. Moreover, the legislation obliges a pharmaceutical company to have obtained either of them, while this pharmaceutical company possesses both certificates. We welcome the new player has entered the market.
This fact will boost competition on the market and make medications more accessible”.
MP Giga Bukia, a member of the parliament’s health committee, appraises the appearance of a new pharmaceutical company in the Georgian market:
“This is a very important event, because market competition will increase and the sharper competition will regulate prices. As to the quality of the generics imported by this company, the tightening of quality control on medications will regulate this issue. In general, there is nothing bad in imports and use of generics. On the contrary, the healthcare expenses will be reduced. Medications will become more affordable for ordinary citizens.
The pharmaceutical market should follow healthy competition principles.
Consequently, the market must be free. Moreover, interested companies should have wider option to enter the market. This is a very important issue for our country. Humanity Georgia is a famous company that possesses quality certificates and medications imported by this company must not be questionable”.
MP Giorgi Gozalishvili, a member of the parliament’s health committee, comments on entrance of Humanity Georgia in the Georgian market:
“This is a very important event, because market competition will increase and the sharper competition will regulate prices. AS to the quality of the generics imported by this company, the tightening of quality control on medications will regulate this issue. In general, there is nothing bad in imports and use of generics. On the contrary, the healthcare expenses will be reduced.
Medications will become more accessible for ordinary citizens.
Marina Shikhashvili, the director at the Tbilisi Family Medicine Training Center, talks about the necessity of use of generics and entrance of a new pharmaceutical company:
“High-quality generics are widely used in the world. Naturally, we also apply branded medications and generics, but the Georgian pharmaceutical market should be regulated, because in most cases generics are more expensive compared to branded medications. Generics are appointed for cost-efficient treatments, as a usual, but today in Georgia generics are more expensive than branded drugs. This direction should be regulated. Therefore, it is difficult to say that generics should be appointed for cost-efficient treatment. At the same time, a doctor must be sure that applicable medications are high-quality products. I cannot say something specific about Humanity Georgia. I have no information and due competence, but I would mark one thing – there are European enterprises in India that meet European standards. The quality of medications of Humanity Georgia is approved by the manufacturer’s EU GMP certificate. Consequently, if the drug is manufactured in India, this fact does not signify the drug is a low-quality product and it does not satisfy the European standards. In general, substantiated arguments should be submitted when casting doubt on efficiency of this or that medication. Therefore, the government should tighten the quality control on medications.
As to the entrance of the new pharmaceutical company, I believe this is a timely and necessary event that will regulate the market prices thanks to healthy competition”.
“I have no valuable information on Humanity Georgia. Anyway, the company is not the first one that will import Indian generics to Georgia. India-manufactured drugs are successfully sold in the pharmacy networks. Drugs may be imported from India, Indonesia, but if it sold in the EU countries too, they are accompanied by due quality certificates and licenses. Therefore, I cannot make their quality questionable. I welcome that the new pharmaceutical company has entered the Georgian pharmaceutical market”, Georgian MP Malkhaz Tsereteli noted and emphasized several positive factors of use of Indian generics:
“Announcement of generics as low-quality drugs comes from unawareness. IN reality, generics represent the so-called mother drugs. Generics are experienced and approbated drugs worldwide. The World Heath Organization has confirmed their quality and efficiency. I personally avoid the medications that may appear in the market from unclear origins as they may not satisfy the standards.
Generics will be beneficial for our population”.
Humanity Georgia represents Humanity Holding GmbH Consortium group of companies founded by strategic partners with the purpose of business opportunities development at the pharmaceutical market of Georgia. The consortium incorporates certified EU – PIC/S GMP pharmaceutical manufacturers which have an ambitious potential in development of pharmaceutical products and product portfolio potential, Project Company, as well as project management and Logistics Company which jointly possess unprecedented combination of international special knowledge and skills at the pharmaceutical market.